UCSF

Topics and Expertise: SARS-CoV-2

UCSF Quantitative Biosciences Institute and Institut Pasteur form center to fight infectious disease

QBI Director Krogan receives the Legion of Honor, France’s highest award

QBI continues research efforts to stave off future surges of COVID-19

Research into SARS-CoV-2 variants and potential therapies pushes forward

A reliable test for COVID-19 immunity

The Wells Lab developed an efficient test for SARS-CoV-2 antibodies

Cancer drug stops SARS-CoV-2 in the lab

“If you get a drug that targets a human protein, it would be incredibly hard for the virus to mutate away from being reliant on it,” said Nevan Krogan, the director of QBI.

Jamming the gears of a deadly virus

Team efforts at the School and beyond produce two potential treatments for COVID-19.